CEO SUMMARY: Automated cytology technology received a big boost when the FDA’s advisory panel voted to recommend that the FDA approve, with conditions, NeoPath’s AutoPap® System as a primary Pap Smear Screener. The company still awaits final FDA approval on this matter. ON JANUARY 28, the Food And Drug Administration’s (FDA) Hematology and Pathology Devices …
Automated Pap Screening Gains Recommendation Read More »
